Committed to transforming
the treatment of severe, chronic
autoimmune diseases.

Committed to transforming
the treatment of severe, chronic
autoimmune diseases.

Van Rompay, Stijn

  • Photo:
  • First name: Stijn
  • Surname: Van Rompay
  • Position: Director – representing SVR Invest – Biogenosis

Stijn Van Rompay joined the Board of Imcyse in 2012. He is an investor with over 20 years’ experience in the private equity and life sciences sectors at senior management and board levels. Stijn co-founded and was CEO of Alter Pharma, a high-growth pharmaceutical company focused on the development of complex generics and pharmacy-related product sales. He was also co-CEO of Uteron Pharma, a company focused on innovative female healthcare products.
Prior to these positions, Stijn was CFO and later, CEO of Docpharma (formerly quoted on Euronext Brussels) a generics and medical-device company. Under his leadership, the companies recorded strong growth and value creation. He also holds several non-executive director positions in the biotech sector, and acts as an advisor to venture capital investors. Stijn holds a Master’s degree in Applied Economics from the University of Antwerp.

Directors

  • Hits: 2263

©imcyse 2023